For Lung cancer, solute carrier family 3 member 2 (SLC3A2) acts as a metabolic switch factor in tumor-associated macrophages (TAM), suggesting that lung adenocarcinoma (LUAD) phenotyping reprogramming occurs via arachidonic acid (Li Z. et al., 2023). This evidence concerns the gene SLC3A2 and lung adenocarcinoma.